Latest Australian And New Zealand Markets News

Page 1 of 2
Inghams Group reports flat revenue but a sharp 42% drop in EBITDA for the first half of FY26, revising full-year earnings guidance lower amid ongoing cost inflation and operational challenges.
Victor Sage
Victor Sage
20 Feb 2026
Algorae Pharmaceuticals has advanced its AI drug discovery capabilities with the launch of AlgoraeOS v2 and secured key commercial partnerships, including a $3 million debt facility to support expansion in Australia and New Zealand.
Ada Torres
Ada Torres
28 Jan 2026
Ampol Limited reports a robust fourth quarter Lytton Refiner Margin of US$15.14 per barrel, underpinning a strong preliminary FY25 earnings update with an expected EBIT of approximately $945 million.
Maxwell Dee
Maxwell Dee
28 Jan 2026
MotorCycle Holdings Limited reported a robust 2025 financial year with record revenue and profit growth, strengthened by key acquisitions that expanded its market share to 22%. The company’s focus on operational efficiency and digital transformation sets the stage for continued momentum in 2026.
Logan Eniac
Logan Eniac
26 Nov 2025
Shriro Holdings reported a 13.6% revenue decline in FY25 amid a strategic shift in its BBQ segment but delivered a 5.5% rise in EBITDA. The company plans a $20 million share buy-back in FY26, signaling confidence in its operational turnaround.
Victor Sage
Victor Sage
17 Nov 2025
Delorean Corporation has transitioned to the operations and maintenance phase at its $53 million Yarra Valley Water bioenergy facility, marking a key milestone in its renewable energy expansion.
Victor Sage
Victor Sage
27 Oct 2025
Amotiv Limited reported steady FY25 financials with marginal revenue growth and a slight EBITA dip, while unveiling its ambitious Amotiv2030 strategy to drive future shareholder value amid ongoing market challenges.
Victor Sage
Victor Sage
24 Oct 2025
EVT Limited reports a robust 20.7% rise in Q1 EBITDA, driven by all divisions, with Hotels leading record results and a strategic acquisition poised to boost earnings further.
Victor Sage
Victor Sage
24 Oct 2025
Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.
Ada Torres
Ada Torres
20 Oct 2025
Shine Justice Ltd reported a 4.4% rise in FY25 revenue to $204.4 million, alongside major legal settlements and leadership changes, signaling renewed growth momentum.
Victor Sage
Victor Sage
28 Aug 2025
Nick Scali Limited reported a solid FY25 underlying profit of $62 million, driven by strong ANZ sales and online growth, while UK operations continue to struggle amid store refurbishments and brand repositioning.
Logan Eniac
Logan Eniac
8 Aug 2025
Entertainment Rewards Ltd reports a 6.1% revenue increase in Q4 FY25, driven by growth in key programs and a new $2.5 million loan facility, while narrowing its operating loss.
Sophie Babbage
Sophie Babbage
29 July 2025